Ahmedabad : Cadila Pharmaceuticals Ltd, launched Risorine,for treatment of tuberculosis in India.This is first prepared drug for treatment of this disease. This Pharma company is based in Gujrat.

This disease is a major reason for  many deaths and illnesses.  1.7 million deaths and 9.2 million new cases occurred in 2006, Globally. India is most TB prevalent country with over 3.4 million tuberculosis patients. With launch of this drug, tuberculosis can be treated in a cost effective manner and efficiently. The huge number of tuberculosis cases detected in India can definitely be cost effective solution and be checked, provided with the help of Risorine, 90 percent of the  patients were treated in cost effective manner and with less side effect.